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Metabolic syndrome (MetS), an important component of insulin resistance and cardiovascular (CV) risk, is de-
fined by 3 or more of the following characteristics: abdominal obesity, hyperglycemia, hypertension, hypertriglyc-
eridemia, and hypo–high-density lipoprotein cholesterolemia. Based on the previously published age- and sex-
mediated DESIR (Data from an Epidemiological Study on the Insulin Resistance Syndrome) cohort and parallel
central hemodynamic measurements, our goal was to evaluate the effects of MetS on brachial central pulse
pressure (PP), PP amplification, aortic stiffness, and wave reflections. These data were then compared with
those of patients with essential hypertension but without MetS for the same mean arterial pressure. Increased
aortic stiffness, a major mechanical factor predicting CV risk, has been well identified as playing a role in MetS.
Its age progression is proportional to the number of risk factors involved in MetS and is responsible for in-
creased systolic blood pressure and decreased diastolic blood pressure with increasing age, the principal hall-
marks of hypertension in the elderly. Beyond brachial pressure measurements, central hemodynamic parame-
ters involve increased aortic stiffness, reduced wave reflections, and increased PP amplification, a parameter
commonly associated with increased heart rate. With the exception of arterial stiffness, all these findings are
opposite in direction to those observed in essential hypertension, in which MetS is absent. A divergent behavior
of wave reflections and PP amplification, but not of arterial stiffness, is observed when hypertension is studied
alone or when compared with MetS for the same mean arterial pressure. This pulsatile hemodynamic abnor-
mality contributes independently to increase age- and sex-mediated CV risk, justifying new research regard-
ing Framingham scores and drug treatment. (J Am Coll Cardiol 2013;61:12–9) © 2013 by the American
College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.01.088Effective cardiovascular (CV) disease prevention requires
that multiple risk factors be addressed simultaneously to
obtain the most significant reduction of morbidity and
mortality in a given population. The combined treatment of
type 2 diabetes mellitus and hypertension is an important
example of this postulate. About 50% of patients with
diabetes have hypertension and 20% of hypertensive pa-
tients have diabetes mellitus. To obtain effective CV disease
prevention, it is necessary to demonstrate that the combi-
nation of antihypertensive and antidiabetic therapy can
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than the sum of each risk factor treated independently.
However, this belief has not been regularly observed in
clinical practice.
In the double-blind ACCORD (Action to Control
Cardiovascular Risk in Diabetes) blood pressure–controlled
study (1), a total of 4,733 patients with diabetes and
hypertension were divided into 2 groups to reach 2 separate
and different brachial systolic blood pressure (SBP) objec-
tives (120 or 140 mm Hg). The final result showed that,
irrespective of the SBP level achieved, the same degree of
reduction of major cardiac and cerebral vascular risk was
observed. These findings suggest that the endpoints of drug
effectiveness should have to be carefully chosen when
therapeutic trials associating the dual goal of diabetes and
hypertension treatments are performed.
Epidemiological studies in hypertension and diabetes
mellitus have shown that factors other than high blood
pressure play a role in the mechanism of CV morbidity and
mortality (2–4). These factors include increased arterial
stiffness, disturbed wave reflections, and altered SBP and/or
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ment, it is important to ask 3 questions: Is arterial stiffness
decreased? Are wave reflections modified? Most impor-
tantly, does peripheral (brachial) PP remain higher than
central PP, as is normally observed (3)? The role of each of
these variables has been previously investigated in numer-
ous epidemiological, clinical, and experimental studies.
However, answers to these questions are not available
associating both hypertension and diabetes mellitus. Fur-
thermore, the roles of age and sex in such populations
have not been shown to be related to arterial stiffness and
wave reflections.
The purpose of the current report was to determine the
possible contribution of aortic stiffness, wave reflections, and
PP amplification to the mechanisms of CV complications
observed in patients with hypertension, diabetes mellitus, or
their combination. In this review, data are provided mainly
from a French research project (DESIR [Data from an
Epidemiological Study on the Insulin Resistance syn-
drome]) (5–7). In this investigation, the metabolic syn-
drome (MetS) is initially analyzed on the basis of age, sex,
and brachial artery blood pressure (mainly brachial artery
PP). The roles of age, sex, and mostly central (carotid) PP
are then investigated in combination with aortic stiffness,
wave reflections, and PP amplification. For simplicity, these
parameters are shown in Figure 1 and further detailed in
this review. Their interrelation was studied to clarify the
pathophysiology of MetS and its attendant CV risk. The
resulting clinical perspectives are discussed in the last part of
this review.
Figure 1 Schematic Representations of the BP Curve
Upper left: the summation of a forward and a backward wave is responsible for
the total blood pressure (BP) curve. Upper right: a schematic representation of
the aortic BP curve with the definitions of augmentation index (AIx) and aug-
mentation pressure. Lower half: the same mean arterial pressure (MAP) may
correspond to different BP curves in younger (left) and older (right) patients.
However, the cross-sectional areas located under each curve remain equal.Brachial Blood Pressure,
Age, Sex, and the
DESIR Study
Basic findings in CV epidemi-
ology. In the past, Richardson
et al. (8), and Franklin et al. (9)
more recently, provided the first
descriptions of the progressive
and chronic change of brachial
blood pressure as a function of
the aging process. Brachial SBP
has been shown to increase mark-
edly and exponentially with age.
Diastolic blood pressure (DBP)
also increases significantly with
age, but at patient age 55 years, it
declines, even without drug treat-
ment. The more recent French
cohort DESIR used a similar design based on brachial artery
blood pressure measurements but was focused almost exclu-
sively on the subject of insulin resistance, its pathophysiology,
and genetic components. DESIR is composed of 4,293 non-
diabetic and diabetic (type 2) men and women age 30 years, all
enrolled as volunteers by the French Social Security System.
Participants of the cohort have been followed up every 3 years
for a total of 9 years on a normal sodium diet, which permits
the assessment of the long-term relationships between brachial
artery blood pressure and age (10,11). First, the mean values of
SBP and DBP, and calculated mean arterial pressure (MAP)
and PP, were plotted in successive age groups and evaluated
separately in men and women (Fig. 2). These plots are similar
to those drawn in previous epidemiological studies. Second, in
a departure from the usual description of SBP, DBP, or PP
versus age, our subsequent studies (10,11) described the rate of
changes of SBP, DBP, or PP versus age. The annual changes
of these parameters were then plotted for both men and
women, as a function of age at study entry (Fig. 3).
Brachial artery blood pressure and age in DESIR. Figure 2
represents the usual linear relationship of brachial SBP with
age and the slightly curvilinear relationship of DBP with
age. The same plot may be observed for MAP.
Because MAP is the product of vascular resistance and
cardiac output and because cardiac output remains within
the normal range in hypertensive and diabetic patients,
MAP is an indirect marker of the changes in the resistance
component of blood pressure with age. Figure 3 illustrates
that while the annual change of SBP increases linearly and
continuously with age, the annual change of DBP initially
increases with age and then begins to decline with age as
early as 45 years. The simultaneous annual increasing
change of SBP and decreasing change of DBP with age
clearly indicates a progressive reduction of arterial distensi-
bility with age, starting around age 45 years. From the
earlier results of Richardson et al. (8) and Franklin et al. (9),
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Hypertension and Metabolic Syndrome January 8, 2013:12–9but in the DESIR study, the annual decline of the change in
DBP with age occurred much earlier.
Brachial pulse pressure and MetS in DESIR. In this
report, the presence of MetS has been defined according to
the National Cholesterol Education Program–Adult
(NCEP) criteria (5). The NCEP criteria are characterized
by 3 or more of the following characteristics: waist circum-
ference 102/88 cm, men/women; fasting glucose 6.1
mol/l or presence of diabetic treatment; SBP 130 mm Hg
nd/or DBP 85 mm Hg; triglycerides 1.69 mmol/l; and
igh-density lipoprotein cholesterol 1.04/1.29 mmol/l,
en/women. It is worth noting that in the NCEP defini-
ion, only brachial SBP and DBP are considered but not
entral blood pressure.
When expressed as mean values (Fig. 4), patients with
etS have a significantly higher brachial PP than those
Figure 2 The DESIR Study: SBP and DBP
Relationships between age and (A) systolic blood pressure (SBP) and (B) diastoli
constantly positive and linear (10,11). DESIR  Data from an Epidemiological Stuithout MetS even if their number was relatively small (83 oen and 34 women) (11). Increased PP was observed both
n men and women and increased exponentially with age in
atients with MetS, mainly due to changes in the intercept
f the curves. However, only in patients with MetS were the
ean values of PP significantly higher in women than in
en. Finally, in DESIR, the 2 populations with and
ithout MetS exhibited a significant sex-interaction regard-
ng 4 different parameters: brachial SBP and PP, body
eight, and waist circumference. All these findings indicate
hat the classification of MetS is complex and that sex plays
n important interactive role.
entral Hemodynamics, Age, Sex, and MetS
entral hemodynamic parameters. Investigations have
een performed in Paris, in a population distinct from that
pressure (DBP) in men and women. Note that the relations are
the Insulin Resistance Syndrome.c blood
dy onf DESIR and studied in Hotel-Dieu Hospital, during a
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detail elsewhere (4,11,12) and include 613 measurements of
carotid–femoral pulse wave velocity (PWV), central and
brachial artery parameters, and study of wave reflections
through augmentation index (AIx) measurements, all per-
formed after drug adjustment if necessary (Fig. 1). Com-
pared with patients without diabetes mellitus, patients with
diabetes mellitus have, for the same age, sex, and MAP,
significantly higher mean values of heart rate, aortic stiff-
ness, and PP amplification but lower mean values of AIx.
Figure 5 (11,13) provides a summary of the main results and
also indicates the corresponding definitions of brachial and
Figure 3 DESIR Study: Yearly Changes in SBP and DBP
Yearly changes () between age and (A) SBP or (B) DBP in men and women (10,
For DBP, the relation is identical in men and women. Abbreviations as in Figure 2.central PP measurements and their ratio.Aortic stiffness. After ventricular contraction, the pressure
pulse generated by the heart travels along the aorta as a
wave. The velocity of propagation of this wave (i.e., PWV)
may be calculated from the arrival time and the distance
between applanated pulses located at 2 different sites in the
arterial tree, such as the carotid and the femoral arteries.
Because a fundamental principle states that pulse waves
travel faster in stiffer arteries, PWV measurement is con-
sidered the best surrogate for the evaluation of aortic
stiffness. Its value in the aorta is approximately 5 m/s in
young persons at rest but increases with age. Aortic PWV is
a strong and independent predictor of overall risk and CV
ote that the relation is positive for SBP and negative for DBP after age 45 years.11). Nrisk in hypertension and diabetes mellitus, particularly in the
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Hypertension and Metabolic Syndrome January 8, 2013:12–9elderly (14,15). PWV increases in MetS in proportion to the
number of MetS criteria and increases with age more rapidly
in patients with MetS than in patients without MetS for the
same MAP (10,11,13,16). In MetS, PWV is associated
with increased values of carotid wall thickness and subcu-
taneous trunk fat but not of carotid plaques or major change
of upper limb PWV (4).
Wave reflections. Small vessels and arterioles are the
principal sites of wave reflections from the incident wave,
Figure 4 Brachial PP
Mean values versus age in men and women with and without metabolic syndrome
Figure 5 Summary of Main Results
Difference in (A) pulse wave velocity, (B) augmentation index, and (C) pulse pres
A similar finding is observed in patients with and without metabolic syndrome. Am
pressure (11,13).and the reflected waves return from the periphery to the
larger thoracic aorta at the same PWV (Fig. 1). Insulin has
significant vasoactive properties, acting independently of the
heart on these resistive vessels and precapillary arterioles
located in muscular and fat tissue. Westerbacka et al. (17)
have shown that, in addition to insulin’s arteriolar effect, it
acts on large arterial vessels through the mechanism of wave
reflections, causing a reduction in amplitude and/or timing
of the carotid pulse under conditions of euglycemic clamp.
) (10,11). PP  pulse pressure.
P) amplification in diabetic (n  126) versus nondiabetic (n  203) patients.
ion  central/brachial PP. p Values are adjusted for age, sex, and mean arterial(MetSsure (P
plificat
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MetS, this physiological mechanism is disrupted and may
contribute to the development of systolic hypertension.
Obviously, the associated roles of endothelin, angiotensin,
or oxidant stress to insulin cannot be excluded from this
simplified description.
PP amplification. The pressure wave changes shape as it
travels down the aorta, such that the blood pressure values
are not identical when measurements are made simultane-
ously at different points (Fig. 1). Whereas SBP and PP
actually rise with distance from the heart, DBP and MAP
fall very slightly (about 2 mm Hg) over the same aortic
course (3). Thus, the pressure oscillation amplitude between
systole and diastole, represented by central PP, nearly
doubles in the periphery (18,19). This pulse amplification is
a result of the arterial stiffness gradient and diameter
narrowing along the arterial tree. It is related to the timing
interaction of the forward ejected and backward reflected
pressure waves at each site of the arterial tree (Fig. 1). Late
synchronization (e.g., at the ascending aorta) of the 2 waves
leads to lower SBP than early synchronization (e.g., at the
descending aorta) for the same MAP (3). Of note, this
timing is highly affected by variations in heart rate (20,21).
The SBP and PP amplification are physiological findings,
which approximate 14 mm Hg between the thoracic aortic
root and the brachial artery, and continue into aortic
ramifications out to about the third-generation level of
branches. AIx is the increase in SBP and PP produced by
the reflected wave and expressed as a percentage of the PP
(Fig. 1). It can be measured from the applanated carotid
pulse and offers a clinical means for assessing the magnitude
of central pressure and wave reflections. The lower the
central AIx, the greater the amplification. Amplification
keeps the central SBP and PP low and protects the heart
against an increase in post-load, but amplification is mark-
edly reduced with increasing age. Disappearance of ampli-
fication is associated with increased amplitude of the central
reflected wave, contributes to increases in the left ventricular
systolic burden, decreases the late systolic ejection flow
velocity (22), and is a significant predictor of CV risk (3,20).
Heart rate. Because heart rate is increased in MetS, the
question is whether high heart rate or wave reflections or
both are major mechanisms accounting for higher amplifi-
cation in this insulin-resistant state. In a cross-sectional
study, we have already shown that PP amplification, HR,
and PWV, but not AIx, are increased in patients with MetS
compared with control patients without MetS but with the
same age, sex, and MAP (18,19). Conversely, the possibility
of an altered ventricular ejection with relatively slower flow
velocity in late systole is also important to consider (22).
However, our results showed that the difference in carotid–
brachial PP amplification between patients with and with-
out MetS disappears after adjustment for both heart rate
and PWV. AIx (Fig. 1), the main clinical index permitting
evaluation of wave reflections in clinical practice, was shown
to be the principal predictor of PP amplification. Althoughthe 2 parameters are inversely related, our results indicate
that AIx represented significantly different contributions
(28% vs. 19%) to the amplification total variance in patients
without and with MetS (18,19).
MetS and the Role of Vascular Factors
in the Assessment of CV Risk
Previously, CV physiologists found that the pulsatile BP
curve was better described when divided into 2 components:
a steady component (MAP) and a pulsatile component (PP)
(21,23). At a given cardiac function, the nonpulsatile
component relates to the status of small arteries (i.e.,
systemic vascular resistance). Conversely, PP that corre-
sponds to the pulsatile flow ejected by the heart is influenced
by 2 distinct parameters of the arterial system: stiffness and
wave reflections. Early epidemiological studies have indi-
cated that, in terms of hazard ratio, MAP best predicts
overall CV risk (brain, heart, and kidney), whereas PP best
predicts coronary risk (23). Such findings show that a new
conceptual approach is necessary to the understanding of
vascular factors in MetS.
Within the microvascular network (24), MetS involves
structural changes of arterioles and capillary rarefaction that
in turn are associated with an increase in vascular resistance
and a resultant increase in MAP. Within the macrocircu-
lation (25), a similar process of vascular remodeling occurs
and increases arterial stiffness, which favors an increase in
SBP but also a decrease in DBP. Finally, in MetS, DBP
level is the result of 2 mechanisms, an increase of systemic
vascular resistance, which tends to increase DBP, and an
increase of arterial stiffness, which is associated with low
DBP. Taken together, all these factors cause an increase in
PP, which, at the level of the central arteries, may be
counterbalanced by the presence of increased heart rate and
blunted wave reflections. Finally, differences in the sexes
might also contribute to accentuation of the role of PP (19).
The circulatory differences between men and women can
be summarized as either hormonal or nonhormonal. Before
menopause, high estrogen levels induce vascular relaxation
through their influence on vascular cell membranes, endo-
thelium, and smooth muscle (26). These effects lead to
increased distensibility of the carotid arteries and aorta.
With menopause, the reduction in estrogen levels and their
associated effects help explain the accelerated CV risks in
women when compared with men of the same age. The
nonhormonal gender differences, however, are lifelong and
even more important to consider than hormonal factors.
They relate to lower body height and size with higher heart
rates and lower cardiac outputs in women. Women’s shorter
stature and shorter length of the arterial tree might be
responsible for their faster heart rate, an acceptable inter-
pretation of their particular biological properties (27).
Shorter stature places the arterial pulse reflecting sites closer
to the heart and, at the same PWV, brings the reflected
wave back into the central aorta earlier in systole with the
18 Safar et al. JACC Vol. 61, No. 1, 2013
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cardiac output, lower stroke volume, and smaller arterial
diameters are lifelong differences, with their possible con-
sequences on the central aorta. Finally, when the association
between diabetes and hypertension is considered, it seems
logical to study PP in men and women separately.
An important consequence of MetS is a progressive and
early inability of the peripheral vascular networks to ade-
quately perfuse skeletal muscle during periods of elevated
metabolic activity. Resulting consequences involve endothe-
lial dysfunction, oxidative stress, and inflammation. Several
features of MetS are characterized by increased production
of reactive oxygen species and nitrogen species and subse-
quent oxidative stress. Antioxidants may limit the oxidative
process by inactivation of free radicals and could protect
patients from MetS-related complications. However, data
from a French randomized controlled trial failed to dem-
onstrate an effect of supplementation with multiple antiox-
idants on MetS risk (28). This finding is in line with most
other primary and secondary prevention trials that found no
beneficial effect of antioxidant supplementation on classical
CV risk factors (29). This lack of benefit may be a simple
reflection of the underlying association with differences in
overall dietary patterns. Hercberg et al. (30) investigated the
association between dietary patterns and PWV measured
7.5 years after the beginning of the diet. The authors
observed a positive correlation between a diet high in
alcohol and meat, and an inverse correlation with diets that
included fiber, vitamins B9 and C, beta-carotene, and
calcium. These findings suggest a role for diet in the
stiffening of large arteries in participants free of known CV
disease.
Conclusion and Prospective Views
This review has shown that the management of hyperten-
sion may differ markedly in the presence or absence of
associated diabetes mellitus and/or MetS. This difference
relates not only to arterial stiffness but also to changes in
other pulsatile hemodynamics such as wave reflections,
PP amplification, and heart rate. Based on multiple
regression analysis, PWV, wave reflections, and PP ampli-
fication are all influenced by age, sex, heart rate, and MAP.
They are also influenced by several glucose-related factors
such as waist circumference. All these factors play a consis-
tent role in blood pressure control when hypertension and
diabetes are associated. Thus, new therapeutic designs
should be proposed for patients with hypertension and
MetS and/or diabetes mellitus. First, the choice of med-
ications causing aortic destiffening should be discussed,
such as those involving angiotensin blockade, calcium
inhibition, and/or diuretics (31). Second, the specific indi-
cations of drugs causing bradycardia should be reviewed,
particularly in patients with diabetes. Third, lifestyle mod-
ifications might be recommended, mainly in the fields of
nutrition (32). Finally, the links of hypoglycemic agents andinsulin with arterial stiffness and wave reflections need to be
more firmly established.
In patients with hypertension, whether or not associated
with diabetes, the principal recommendation for drug treat-
ment is to reduce SBP (130 or 140 mm Hg) and DBP
(80 or 90 mm Hg). This recommendation agrees with
traditional aspects of CV epidemiology, which highlight the
role of both elevated SBP and DBP as dominant vascular
factors acting on CV risk (4). However, CV epidemiology
now indicates that arterial stiffness is another independent
factor to consider in the reduction of CV risk and Framing-
ham scores (19,33). In the context of the combination of
hypertension and diabetes, the presence of increased arterial
stiffness requires the reduction of SBP but also the need to
maintain and/or even increase DBP. Although counterin-
tuitive, low DBP is alone a significant risk factor for cardiac
complications, particularly in the elderly. Finally, in the
context of treatment of hypertension associated with diabe-
tes, we suggest that experts working in both fields should
critically review therapeutic recommendations. CV risk is
usually assessed by using Framingham scores, which involve
a number of metabolic factors but only SBP and DBP as
mechanical factors. Research by Mitchell et al. (34) has
shown that, in patients assessed after a first CV event, the
introduction of PWV into the panel of the Framingham
score may significantly improve the quantification of CV
risk. CV risk assessment could be further improved if
wave reflection and PP amplification were also taken into
account in patients who have both hypertension and
diabetes mellitus.
Units of tables and figures may differ from each other
since the form in their original publication has been re-
tained; see text.
Acknowledgments
This work was performed with the help of Groupe de
Pharmacologie et d’Hémodynamique Cardiovasculaire,
Paris. The authors thank Dr. Anne Safar for helpful and
stimulating discussions.
Reprint requests and correspondence: Dr. Michel Safar, Centre
de Diagnostic et de Thérapeutique, Hôtel-Dieu, 1, place du Parvis
Notre-Dame, 75181 Paris Cedex 04, France. E-mail: michel.
safar@htd.aphp.fr.
REFERENCES
1. Cushman WC, Evans GW, Byington RP, et al. Effects of intensive
blood-pressure control in type 2 diabetes mellitus. N Engl J Med
2010;362:1575–85.
2. Agabiti-Rosei E, Mancia G, O’Rourke MF, et al. Central blood
pressure measurements and antihypertensive therapy: a consensus
document. Hypertension 2007;50:154–60.
3. Avolio AP, Van Bortel LM, Boutouyrie P, et al. Role of pulse pressure
amplification in arterial hypertension: experts’ opinion and review of
the data. Hypertension 2009;54:375–83.
4. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes
and the metabolic syndrome: a pathway to cardiovascular disease.
Diabetologia 2008;51:527–39.
19JACC Vol. 61, No. 1, 2013 Safar et al.
January 8, 2013:12–9 Hypertension and Metabolic Syndrome5. Balkau B, Vernay M, Mhamdi L, et al. The incidence and persistence
of the NCEP (National Cholesterol Education Program) metabolic
syndrome. The French D.E.S.I.R. study. Diabetes Metab 2003;29:
526–32.
6. Balkau B, Simon D. Survival in people with type 2 diabetes as a
function of HbA(1c). Lancet 2010;375:438–40.
7. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F. Nine-year incident
diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study.
BMC Gastroenterol 2010;10:56.
8. Richardson DW, Honour AJ, Fenton GW, Stott FH, Pickering GW.
Variation in arterial pressure throughout the day and night. Clin Sci
1964;26:445–60.
9. Franklin SS, Gustin W 4th, Wong ND, et al. Hemodynamic patterns
of age-related changes in blood pressure. The Framingham Heart
Study. Circulation 1997;96:308–15.
10. Safar ME, Lange C, Tichet J, Blacher J, Eschwege E, Balkau B. The
Data from an Epidemiologic Study on the Insulin Resistance Syn-
drome Study: the change and the rate of change of the age-blood
pressure relationship. J Hypertens 2008;26:1903–11.
11. Safar ME, Lange C, Blacher J, Eschwege E, Tichet J, Balkau B. Mean
and yearly changes in blood pressure with age in the metabolic
syndrome: the DESIR study. Hypertens Res 2011;34:91–7.
12. Westerbacka J, Tamminen M, Cockcroft J, Yki-Jarvinen H. Compar-
ison of in vivo effects of nitroglycerin and insulin on the aortic pressure
waveform. Eur J Clin Invest 2004;34:1–8.
13. Protogerou AD, Achimastos A, Lekakis JP, Papaioannou TG, Blacher
J. Is increased brachial pulse pressure a reliable predictor of cardiovas-
cular risk in old hypertensive subjects with metabolic syndrome? Am J
Hypertens 2007;20:1024–5; author reply 1025–6.
14. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse
wave velocity as a marker of cardiovascular risk in hypertensive
patients. Hypertension 1999;33:1111–7.
15. Meaume S, Benetos A, Henry O, Rudnichi A, Safar ME. Aortic pulse
wave velocity predicts cardiovascular mortality in subjects70 years of
age. Arterioscler Thromb Vasc Biol 2001;21:2046–50.
16. Safar ME, Thomas F, Blacher J, et al. Metabolic syndrome and
age-related progression of aortic stiffness. J Am Coll Cardiol 2006;47:
72–5.
17. Westerbacka J, Seppala-Lindroos A, Yki-Jarvinen H. Resistance to
acute insulin induced decreases in large artery stiffness accompanies the
insulin resistance syndrome. J Clin Endocrinol Metab 2001;86:
5262–8.
18. Protogerou AD, Blacher J, Mavrikakis M, Lekakis J, Safar ME.
Increased pulse pressure amplification in treated hypertensive subjects
with metabolic syndrome. Am J Hypertens 2007;20:127–33.
19. Protogerou AD, Blacher J, Aslangul E, et al. Gender influence on
metabolic syndrome’s effects on arterial stiffness and pressure wave
reflections in treated hypertensive subjects. Atherosclerosis 2007;193:
151–8.20. Benetos A, Thomas F, Joly L, et al. Pulse pressure amplification, a
mechanical biomarker of cardiovascular risk. J Am Coll Cardiol
2010;55:1032–7.
21. Nichols WW, O’Rourke MF. McDonald’s Blood Flow In Arteries.
Theoretical, Experimental and Clinical Principles. 4th edition. Lon-
don: Arnold E, 2006:49–94, 193–233, 339–402, 435–502.
22. Miyashita H, Ikeda U, Tsuruya Y, Sekiguchi H, Shimada K, Yagi-
numa T. Noninvasive evaluation of the influence of aortic wave
reflection on left ventricular ejection during auxotonic contraction.
Heart Vessels 1994;9:30–9.
23. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on
arterial stiffness and pulse pressure in hypertension and cardiovascular
diseases. Circulation 2003;107:2864–9.
24. Czernichow S, Greenfield JR, Galan P, et al. Microvascular dysfunc-
tion in healthy insulin-sensitive overweight individuals. J Hypertens
2010;28:325–32.
25. Czernichow S, Greenfield JR, Galan P, et al. Macrovascular and
microvascular dysfunction in the metabolic syndrome. Hypertens Res
2010;33:293–7.
26. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J
Physiol Regul Integr Comp Physiol 2004;286:R233–49.
27. Smulyan H, Asmar RG, Rudnicki A, London GM, Safar ME.
Comparative effects of aging in men and women on the properties of
the arterial tree. J Am Coll Cardiol 2001;37:1374–80.
28. Czernichow S, Vergnaud AC, Galan P, et al. Effects of long-term
antioxidant supplementation and association of serum antioxidant
concentrations with risk of metabolic syndrome in adults. Am J Clin
Nutr 2009;90:329–35.
29. Steinhubl SR. Why have antioxidants failed in clinical trials? Am J
Cardiol 2008;101:14D–9D.
30. Hercberg S, Castetbon K, Czernichow S, et al. The Nutrinet-Santé
Study: a web-based prospective study on the relationship between
nutrition and health and determinants of dietary patterns and nutri-
tional status. BMC Public Health 2010;10:242.
31. Safar ME, Blacher J, Jankowski P. Arterial stiffness, pulse pressure,
and cardiovascular disease—is it possible to break the vicious circle?
Atherosclerosis 2011;218:263–71.
32. Dengo AL, Dennis EA, Orr JS, et al. Arterial destiffening with weight
loss in overweight and obese middle-aged and older adults. Hyperten-
sion 2010;55:855–61.
33. Mitchell GF, Wang N, Palmisano JN, et al. Hemodynamic correlates
of blood pressure across the adult age spectrum: noninvasive evaluation
in the Framingham Heart Study. Circulation 2010;122:1379–86.
34. Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and
cardiovascular events: the Framingham Heart Study. Circulation
2010;121:505–11.Key Words: arterial stiffness y hypertension y metabolic syndrome.
